BioSpace News Archive

Business

Cosette Pharmaceuticals and Alembic Pharmaceuticals Limited Announce the Approval and Launch of a National Brand Equivalent (NBE) of Abreva® (Docosanol Cream 10%) Including the First Approval in the Pump Format

Cosette Pharmaceuticals, Inc (“Cosette”), in collaboration with Aleor Dermaceuticals, a wholly owned subsidiary of Alembic Pharmaceuticals (“Alembic”; BSE: 533573), announced that the U.S. Food and Drug Administration (FDA) has approved the Abbreviated New Drug Application (ANDA) for an NBE version of Abreva® (Docosanol cream 10%) in a 2 gm tube and pump formats.

May 24, 2022
·
2 min read
Biotech Beach

Eclipsebio to Present Data and Unveil Antibody Barcode CLIP, a Novel Multiplexed CLIP Technology, at the RNA Society Annual Meeting 2022

Eclipse Bioinnovations, Inc. (Eclipsebio), the leading RNA genomics company developing and commercializing novel, data-driven technologies that interrogate RNA, today announced the presentation of data describing a novel multiplexed cross-linking immunoprecipitation (CLIP) technology, called Antibody Barcode CLIP, at the 27th Annual Meeting of the RNA Society.

May 24, 2022
·
2 min read